微信平台在冠心病PCI术后患者健康教育中的应用
|
摘要
目的:分析微信平台在冠心病经皮冠状动脉介入(PCI)术后患者健康教育中的应用效果。方法:选择2016年6月到2017年12月在海南省人民医院心血管内科接受住院治疗的94例行PCI治疗的冠心病患者,其中2016年6月到2017年7月收治的44例患者作为对照组,2017年8—12月收治的50例患者作为观察组。对照组在术后给予常规护理,观察组在对照组护理的基础上给予基于微信平台的康复宣教指导,两组护理观察时间为3个月。结果:护理后观察组的总有效率为98.0%,对照组为86.4%,观察组显著好于对照组(P <0.05)。观察组护理第1个月、3个月的服药依从性得分都显著高于对照组(P <0.05)。护理后两组的LVDd值显著降低、LVEF值显著增加,与护理前比较均有统计学差异(P <0.05);护理后观察组的LVDd、LVEF值与对照组比较也有统计学差异(P <0.05)。结论:基于微信平台的康复宣教指导在冠心病PCI术后患者中的应用能提高服药依从性,改善预后疗效与患者的心功能。
Objective: To discuss about the feasibility of WeChat platform in health education in patients after percutaneous coronary intervention(PCI). Methods: 94 patients with coronary heart disease who received PCI treatment in the Department of Cardiovascular Medicine of Hainan Central Hospital from June 2016 to December 2017 were selected. 44 patients received from June 2016 to July2017 were considered as the control group, and 50 patients received from August 2017 to December 2017 were considered as the observation group. The control group was given routine nursing after operation, while the observation group was given rehabilitation education guidance based on Wechat platform on the basis of nursing of the control group. The nursing observation time of the two groups was 3 months. Results: After nursing, the total effective rate of the observation group was 98.0%, and that of the control group was 86.4%. The observation group was significantly better than the control group(P <0.05). The scores of medication compliance of the observation group were significantly higher than those of the control group in the first and third month of nursing(P <0.05).After nursing, the LVDd and LVEF values of the two groups decreased significantly and increased significantly, respectively, significant different from those before nursing(P <0.05); and after nursing, the LVDd and LVEF values of the observation group were also significantly different from those of the control group(P <0.05). Conclusion: The application of rehabilitation education guidance based on WeChat platform in patients with coronary heart disease after PCI can improve the medication compliance, prognosis, curative effect and cardiac function of patients.
Objective: To discuss about the feasibility of WeChat platform in health education in patients after percutaneous coronary intervention(PCI). Methods: 94 patients with coronary heart disease who received PCI treatment in the Department of Cardiovascular Medicine of Hainan Central Hospital from June 2016 to December 2017 were selected. 44 patients received from June 2016 to July2017 were considered as the control group, and 50 patients received from August 2017 to December 2017 were considered as the observation group. The control group was given routine nursing after operation, while the observation group was given rehabilitation education guidance based on Wechat platform on the basis of nursing of the control group. The nursing observation time of the two groups was 3 months. Results: After nursing, the total effective rate of the observation group was 98.0%, and that of the control group was 86.4%. The observation group was significantly better than the control group(P <0.05). The scores of medication compliance of the observation group were significantly higher than those of the control group in the first and third month of nursing(P <0.05).After nursing, the LVDd and LVEF values of the two groups decreased significantly and increased significantly, respectively, significant different from those before nursing(P <0.05); and after nursing, the LVDd and LVEF values of the observation group were also significantly different from those of the control group(P <0.05). Conclusion: The application of rehabilitation education guidance based on WeChat platform in patients with coronary heart disease after PCI can improve the medication compliance, prognosis, curative effect and cardiac function of patients.
引文
[1] Reczuch K,Milewski K,Wsek W,et al.Bioresorbable scaffolds in the treatment of coronary artery disease//Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society(ACVI PCS)[J].Kardiol Pol,2017,75(8):817-835.
[2] Grimfjard P,James S,Persson J,et al.Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold//The Swedish Coronary Angiography andAngioplasty Registry(SCAAR)[J].EuroInterven tion,2017,13(11):1303-1310.
[3]肖路花,林青,于娜英.微信公众号的延续性护理在粒子植入治疗肺癌患者健康教育中的应用[J].现代临床护理,2017,16(2):30-33.
[4] Schoos M,Chandrasekhar J,Baber U,et al.Causes,timing,and impact of dual antiplatelet therapy interruption for surgery//Patterns of non-adherence to anti-platelet regimens in stented patients registry[J].Am J Cardiol,2017,120(6):904-910.
[5] Jensen BES,Hansen JM,Larsen KS,et al.Randomized clinical trial:the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy[J].Eur J Gastroenterol Hepatol,2017,29(10):1118-1125.
[6] Chandrasekhar J,Baber U,Sartori S,et al.Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main//proximal LAD versus other PCI:Results from the Patterns of NonAdherence to Dual Antiplatelet Therapy in Stented Patients(PARIS)registry[J].Int J Cardiol,2017,15(243):132-139.
[7] Lin H,Zhang YM.The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients[J].Int J Cardiol,2017,1(242):1-3.
[2] Grimfjard P,James S,Persson J,et al.Outcome of percutaneous coronary intervention with the Absorb bioresorbable scaffold//The Swedish Coronary Angiography andAngioplasty Registry(SCAAR)[J].EuroInterven tion,2017,13(11):1303-1310.
[3]肖路花,林青,于娜英.微信公众号的延续性护理在粒子植入治疗肺癌患者健康教育中的应用[J].现代临床护理,2017,16(2):30-33.
[4] Schoos M,Chandrasekhar J,Baber U,et al.Causes,timing,and impact of dual antiplatelet therapy interruption for surgery//Patterns of non-adherence to anti-platelet regimens in stented patients registry[J].Am J Cardiol,2017,120(6):904-910.
[5] Jensen BES,Hansen JM,Larsen KS,et al.Randomized clinical trial:the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy[J].Eur J Gastroenterol Hepatol,2017,29(10):1118-1125.
[6] Chandrasekhar J,Baber U,Sartori S,et al.Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main//proximal LAD versus other PCI:Results from the Patterns of NonAdherence to Dual Antiplatelet Therapy in Stented Patients(PARIS)registry[J].Int J Cardiol,2017,15(243):132-139.
[7] Lin H,Zhang YM.The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients[J].Int J Cardiol,2017,1(242):1-3.